Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7KFZ

Structure of a ternary KRas(G13D)-SOS complex

7KFZ の概要
エントリーDOI10.2210/pdb7kfz/pdb
EMDBエントリー22857
分子名称GTPase KRas, Son of sevenless homolog 1, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, ... (4 entities in total)
機能のキーワードras, sos, gtpase, hydrolase-signaling protein complex, hydrolase/signaling protein
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数3
化学式量合計96769.89
構造登録者
Liu, C.,Moghadamchargari, Z.,Laganowsky, A.,Zhao, M. (登録日: 2020-10-15, 公開日: 2021-03-31, 最終更新日: 2024-03-06)
主引用文献Moghadamchargari, Z.,Shirzadeh, M.,Liu, C.,Schrecke, S.,Packianathan, C.,Russell, D.H.,Zhao, M.,Laganowsky, A.
Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
Proc.Natl.Acad.Sci.USA, 118:-, 2021
Cited by
PubMed Abstract: Ras is regulated by a specific guanine nucleotide exchange factor Son of Sevenless (SOS), which facilitates the exchange of inactive, GDP-bound Ras with GTP. The catalytic activity of SOS is also allosterically modulated by an active Ras (Ras-GTP). However, it remains poorly understood how oncogenic Ras mutants interact with SOS and modulate its activity. Here, native ion mobility-mass spectrometry is employed to monitor the assembly of the catalytic domain of SOS (SOS) with KRas and three cancer-associated mutants (G12C, G13D, and Q61H), leading to the discovery of different molecular assemblies and distinct conformers of SOS engaging KRas. We also find KRas exhibits high affinity for SOS and is a potent allosteric modulator of its activity. A structure of the KRas•SOS complex was determined using cryogenic electron microscopy providing insight into the enhanced affinity of the mutant protein. In addition, we find that KRas-GTP can allosterically increase the nucleotide exchange rate of KRas at the active site more than twofold compared to KRas-GTP. Furthermore, small-molecule Ras•SOS disruptors fail to dissociate KRas•SOS complexes, underscoring the need for more potent disruptors. Taken together, a better understanding of the interaction between oncogenic Ras mutants and SOS will provide avenues for improved therapeutic interventions.
PubMed: 33723061
DOI: 10.1073/pnas.2022403118
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.47 Å)
構造検証レポート
Validation report summary of 7kfz
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon